On June 12, ProxsysRx opened its pharmacy in Holyoke Medical Center — a 198-bed independent community hospital in Holyoke, Massachusetts. The pharmacy is currently offering full retail service, and some patient-discharge prescription support (Meds To Beds), but the Employee Prescription plan still has a few hurdles to overcome. It’s a still-unfinished process that began when … Read More
Terrebone Pharmacist-In-Charge Derel Smith Is “At Home” In Houma
Few corporate ladders in the retail pharmacy world rise higher than Derel Smith’s did. As former Director of Pharmacy Operations for a major regional retailer, he managed oversight of nearly 600 pharmacies. It was a position nearly 30 years in the making, and one that afforded him an enviable lifestyle in Orlando. So why, you’d … Read More
The 2023 Guide To Implementing An Effective 340B Program
The 340B-program landscape has changed dramatically. For the 340B program’s first 28 years after its 1992 inception, the basic list of Best Practices for eligible entities (the 340B basics, if you will) remained largely unchanged — aside from the dramatically-increased importance of using specialized software. But since the June, 2020 introduction of 340B ESP — … Read More
The Prescription-Discount Advantage For Self-Insured Companies. And Their Employees.
MedServRx: No prescription card saves more. Or delivers more. Not only does MedServRx offer savings of up to 80% (sometimes even more), it gives participating self-insured companies access to prescription-fulfillment data that’s commonly lost when patients use other prescription-discount cards. The MedServRx card, and all of the prescription-data reporting it delivers, are available at no … Read More
Why 340B Hospitals Should Now Build Their Own Specialty Pharmacies
340B ESP and drug manufacturer restrictions are only part of the reason As we noted in a previous post, for 340B-eligible hospitals dealing with increasingly squeezed bottom lines, an in-house specialty pharmacy offers enormous savings and revenue potential. Some covered entities generate as much as 600% in specialty pharmacy revenue from 340B drugs as they … Read More
Manufacturers Accelerate Pace And Severity Of 340B Drug Pricing Restrictions
There’s an old saying that it’s better to be rich and guilty than poor and innocent. It’s a sad truth that accurately reflects the current state of 340B manufacturer restrictions, particularly in the wake of the January 30, 2023 decision by the U.S. Court of Appeals for the Third Circuit — which was largely in … Read More
ProxsysRx’s MedServRx: The Prescription-Drug Advantage For Patients And Their Providers
In the fall of 2022, ProxsysRx set-out to extend its pharmacy-based services to hospitals, their affiliated physicians and their patients by offering a multi-benefit prescription savings card. One that helps make unaffordable drugs more affordable, while increasing patients’ access to medications through prescription discounts. Just as importantly, a card that gives participating health systems access … Read More
How 340B Programs Can Positively Impact Value-Based Care Scores
It’s no secret that, for hospitals, one of the Affordable Care Act’s most far-reaching legacies is the impact that Value-Based Care has on the payments they receive. For many health systems, the lower their Value-Based Care scores, the lower the payments they receive from treating Medicare and Medicaid patients. What isn’t as commonly considered — … Read More
Brick Walls: Dealing With 340B Manufacturer Restrictions.
A ProxsysRx Team Member Speaks Out. I joined ProxsysRx in early 2021, and I’ve been devoted to 340B program management full-time since early 2022. I’m no stranger to heavily regulated programs. Nearly my whole professional career has been in some aspect of public health — preclinical, clinical and now post-clinical. I’m currently fully devoted to … Read More
The Ultimate Shame Of 340B ESP and Drug Manufacturer Restrictions
Making the rich richer at the expense of the poorest and most vulnerable. Why was the 340B program created? Nobody’s ever put it better than the Association of American Medical Colleges (AAMC): “Congress created the 340B Drug Pricing Program in 1992 to protect safety-net hospitals from escalating drug prices by allowing them to purchase outpatient … Read More